ArticleMolecular neurobiology2025
Insight into Apert Syndrome: Reporting on Six Patients and Increasing Awareness.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Apert Syndrome: Oral, Maxillofacial and Dental Management-A Narrative Clinical Review.Clinics and practice · 2026Review
- The Impact of Genetics on Craniofacial Dysplasias and Consequent Oral Malformations-Integrative Review.Genes · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Apert syndrome (AS) is a rare autosomal dominant disorder characterized by various congenital malformations. In this study, we aimed to explore the clinical presentation of Apert syndrome to enhance awareness among multidisciplinary healthcare providers regarding its differential diagnosis through the phenotype/genotype characterization of six Egyptian patients with AS. We examined six patients with Apert syndrome: four females and two males (2:1), aged 3 to 7 years. Clinical examination, along with pedigree analysis, was followed by DNA extraction from the patients' and their parents' peripheral blood leukocytes for genomic screening of FGFR2 gene variations. Key findings in all patients included craniosynostosis and distinctive facial features such as midface hypoplasia, exophthalmos, hypertelorism, a beaked nose, a prominent forehead, and an underdeveloped upper jaw, along with syndactyly of the hands and feet. We identified oral anomalies such as cleft palate, bifid uvula, impacted teeth, delayed eruption, supernumerary teeth, and thick gingiva. Pathogenic variants of the FGFR2 gene were characterized in all six patients. This report presents the largest cohort of Apert syndrome among Egyptian patients. Raising awareness about AS, especially among various interdisciplinary teams, is essential for managing this rare condition and is crucial for accurate diagnosis and timely medical and surgical intervention. Proper diagnosis and genetic counseling are necessary for improving survival and preventing the recurrence of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.